Video
GLP-1s must now include warning for potential increased risk of vision loss, FDA announces
The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.
Source: CBS Health · Mon, 09 Nov 2026 19:44:00 -0500





Leave A Reply
Sign in to leave a comment